calciol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
calciol — no detected effect on all-cause mortality
Evidence strength: very limited.FindingNull resultreplicated ×5“Hospital mortality and 6-month mortality were also not significantly different (hospital mortality: 28.3% [95% CI, 22.6%-34.5%] for vitamin D3 vs 35.3% [95% CI, 29.2%-41.7%] for placebo; hazard ratio [HR], 0.81 [95% CI, 0.58-1.11]; P = .18; 6-month mortality: 35.0% [95% CI, 29.0%-41.5%] for vitamin D3 vs 42.9% [95% CI, 36.5%-49.4%] for placebo; HR, 0.78 [95% CI, 0.58-1.04]; P = .09).”
Quoted verbatim from Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.. - Study
- RCT
- Duration
- 6 months
- Dose
- vitamin D3 540,000 IU once, then 90,000 IU monthly for 5 months, versus placebo
- Population
- Critically ill adult patients in ICUs with vitamin D deficiency (25-hydroxyvitamin D 20 ng/mL or below); 6-month mortality horizon
Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.2014PMID:2526829510.1001/jama.2014.13204Permalink
To cite this finding: https://catalystproject.ai/e/01M5KTEYNTFARACGEPDPPY208C